Business

3D EYE Solutions Announces a Shareholders Update on Our Expanded Cannabis Division

3D EYE Solutions Announces a Shareholders Update on Our Expanded Cannabis Division.

articleStella Diagnostics Inc.June 18, 20143/company/jmd-properties-inc/news/3d-eye-solutions-announces-a-shareholders-update-on-our-expanded-cannabis-division
3D EYE Solutions Announces a Shareholders Update on Our Expanded Cannabis Division

About this update from Stella Diagnostics Inc.

[{"type":"text","content":"\n \n \n 3D EYE Solutions Announces a Shareholders Update on Our Expanded Cannabis Division\n \n \n3D EYE Solutions Announces a Shareholders Update on Our Expanded Cannabis Division\n \n CHEYENNE, WY--(Marketwired - Jun 18, 2014) - 3D Entertainment Holdings, Inc., a Wyoming Corporation dba 3D Eye Solutions Inc (OTC Pink: TDEY) (PINKSHEETS: TDEY)\n 3D EYE Solutions, Inc. (TDEY). Announces The following updates to our newly expanded Cannabis Division. The company would like to provide the following details on its plans to expand its Cannabis infused division.\n 3D EYE Solutions would like to announce the following plans for its rapid expansion into the Cannabis and Marijuana infused sector. The company has identified a core product and services line specifically targeting the budding Cannabis marketplace. We are currently developing our proprietary ERP software MaryGen and anticipate strong market demand for our product market wide as more states legalizes Cannabis sales and use. We also recently announced our newest Marijuana Infused product Cannastix, which we believe is a \"one step solution\" to the current issues facing the Cannabis infused edibles market. Cannabis infused edibles continue to show the greatest increases in demand growth while continuing to be a \"problem\" for manufacturing and distribution channels due to shelf life and market wide regulation. We are also preparing two completely unique products to the Cannabis marketplace which we feel will be comparable \"cover all\" products which will revolutionize and surpass cost, distribution, and regulatory issues that dog many Cannabis infused products making it difficult or even impossible for mass distribution. We will be debuting these products to the marketplace over the next two months.\n The company feels the next natural step in growth will be establishing a physical presence in Colorado and Washington St by either acquisition and/or outright real estate purchase for manufacturing and development and possible stand-alone grow and retail opportunities. We will be surveying all available opportunities in these areas and are also looking to acquire properties in Florida as we anticipate major demand there and would like to establish a footprint ahead of legalization. This strategy fits our business model and will allow for growth of physical assets along with me...

More updates from Stella Diagnostics Inc.